β€οΈ Single-Cell Machine Learning Reveal a Fibroblast-Centric Program in Ischemic Cardiomyopathy
Why do some hearts continue to deteriorate long after the initial ischemic injury?
A new study in Chemical Biology & Drug Design combined single-cell RNA sequencing, machine learning, immune deconvolution, pseudotime analysis, virtual gene knockout, and molecular docking to uncover the cellular programs driving ischemic cardiomyopathy (ICM).
The investigators integrated scRNA-seq data with four independent transcriptomic cohorts, creating a high-resolution cellular atlas of human ICM. Among 127 machine-learning model combinations, a robust 5-gene diagnostic signature emerged:
𧬠NPPA
𧬠HTRA1
𧬠LUM
𧬠ASPN
𧬠OGN
These genes consistently achieved strong diagnostic performance across independent datasets (AUC > 0.83).
The most striking finding?
All five genes were predominantly expressed in cardiac fibroblasts, identifying fibroblasts as a central orchestrator of ischemic remodeling. Single-cell analyses showed these genes were consistently upregulated in ICM hearts, particularly within fibroblast populations.
Functional analyses pointed toward a shared biological theme:
β‘ Oxidative stress
β‘ Mitochondrial dysfunction
β‘ Extracellular matrix remodeling
β‘ TGF-Ξ² signaling
β‘ Inflammatory regulation
Virtual knockout experiments revealed that disruption of ASPN, HTRA1, LUM, or OGN consistently perturbed inflammatory-response pathways, highlighting a fibroblast-driven inflammatory network that may fuel disease progression.
Immune profiling added another layer.
ICM samples showed:
β¬οΈ Increased fibroblast infiltration
β¬οΈ Increased plasma cells
β¬οΈ Reduced monocytes and M2 macrophages
Moreover, all five hub genes strongly correlated with fibroblast abundance, linking fibrosis and immune remodeling into a unified disease program.
The therapeutic angle is particularly interesting.
Computational drug repositioning identified LDN-193189, a BMP type-I receptor inhibitor, as the top candidate. Molecular docking predicted strong binding to ASPN, LUM, and OGN, with binding energies below β9 kcal/mol, suggesting potential anti-fibrotic activity in ICM.
Why this matters
Heart failure research has traditionally focused on cardiomyocytes. This study shifts attention toward fibroblast-centered inflammatory remodeling, suggesting that fibroblasts are not merely scar-forming cells but active regulators of oxidative stress, immune signaling, and disease progression.
The combination of single-cell biology, machine learning, and in silico therapeutics provides a blueprint for discovering actionable targets in complex cardiovascular diseases.
Reference
Yu G, Kan T, Shen J, et al. Integrated Single-Cell and Machine Learning Analysis Identifies Fibroblast-Associated Hub Genes and Potential Therapeutics in Ischemic Cardiomyopathy. Chemical Biology & Drug Design (2026). DOI: 10.1111/cbdd.70329.
#Cardiology #HeartFailure #IschemicCardiomyopathy #SingleCellRNAseq #MachineLearning #Fibroblasts #CardiacFibrosis #SystemsBiology #DrugDiscovery #PrecisionMedicine #Bioinformatics #CardioResearch